CellAegis Announces First Patients Enrolled in U.S. Shield Pivotal Clinical Trial
TORONTO, Canada, April 10, 2018 (GLOBE NEWSWIRE) – CellAegis Devices Inc. (“CellAegis” or the “Company”),...
Search for Articles
Apr 10, 2018
Mar 12, 2018
Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation
COPENHAGEN, Denmark— 12 March 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company...
Mar 8, 2018
Vectorious closes B round, setting stage for trials of heart-monitoring implant
Vectorious Medical Technologies has raised cash to trial an implant for monitoring left atrial pressure...
Feb 8, 2018
Acesion Pharma Receives Approval for Phase I Study in Atrial Fibrillation
COPENHAGEN, Denmark— 8 February 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company...
Jan 29, 2018
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results
ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC Houston, TX, USA, January...
Nov 21, 2017
480 Biomedical’s Novel Technology Featured in Nature Materials
480 Biomedical develops new technology which imparts metal-like strength on bioresorbable polymers WATERTOWN, Mass., Nov. 21,...